-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Orchard Therapeutics plc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2022.
- Orchard Therapeutics plc Nonoperating Income (Expense) for the quarter ending September 30, 2023 was -$12.7M, a 45.1% increase year-over-year.
- Orchard Therapeutics plc Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was $29M.
- Orchard Therapeutics plc annual Nonoperating Income (Expense) for 2022 was -$25.9M, a 681% decline from 2021.
- Orchard Therapeutics plc annual Nonoperating Income (Expense) for 2021 was -$3.32M, a 178% decline from 2020.
- Orchard Therapeutics plc annual Nonoperating Income (Expense) for 2020 was $4.27M, a 40.8% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)